Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitral Valve Insufficiency | 19 | 2022 | 1356 | 3.310 |
Why?
|
| Mitral Valve | 16 | 2022 | 1458 | 2.150 |
Why?
|
| Echocardiography, Three-Dimensional | 6 | 2020 | 599 | 1.270 |
Why?
|
| Mitral Valve Prolapse | 3 | 2020 | 221 | 0.940 |
Why?
|
| Papillary Muscles | 3 | 2019 | 199 | 0.760 |
Why?
|
| Chordae Tendineae | 2 | 2016 | 44 | 0.750 |
Why?
|
| Mitral Valve Stenosis | 2 | 2020 | 380 | 0.740 |
Why?
|
| Adaptation, Physiological | 5 | 2018 | 1338 | 0.690 |
Why?
|
| Rheumatic Heart Disease | 1 | 2018 | 174 | 0.620 |
Why?
|
| Heart Valve Diseases | 2 | 2022 | 1057 | 0.580 |
Why?
|
| Aortic Valve Stenosis | 3 | 2022 | 1855 | 0.510 |
Why?
|
| Myocardial Infarction | 7 | 2020 | 11423 | 0.500 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2019 | 501 | 0.470 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2015 | 268 | 0.450 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 4030 | 0.430 |
Why?
|
| Echocardiography | 4 | 2020 | 5099 | 0.340 |
Why?
|
| Mitral Valve Annuloplasty | 2 | 2020 | 152 | 0.330 |
Why?
|
| Aortic Valve | 3 | 2022 | 1835 | 0.220 |
Why?
|
| Intuition | 1 | 2020 | 14 | 0.200 |
Why?
|
| Sheep | 4 | 2017 | 1477 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 2 | 2022 | 1502 | 0.190 |
Why?
|
| Septal Occluder Device | 1 | 2019 | 125 | 0.170 |
Why?
|
| Ventricular Remodeling | 3 | 2017 | 1273 | 0.160 |
Why?
|
| Atrial Appendage | 1 | 2019 | 255 | 0.140 |
Why?
|
| Losartan | 1 | 2017 | 265 | 0.140 |
Why?
|
| Sheep, Domestic | 2 | 2017 | 48 | 0.140 |
Why?
|
| Eligibility Determination | 1 | 2018 | 384 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2017 | 718 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 3 | 2017 | 1997 | 0.130 |
Why?
|
| Echocardiography, Doppler | 1 | 2018 | 960 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 1 | 2016 | 407 | 0.120 |
Why?
|
| Rupture | 1 | 2014 | 430 | 0.120 |
Why?
|
| Myocardial Ischemia | 2 | 2016 | 2136 | 0.110 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2022 | 1487 | 0.110 |
Why?
|
| Warfarin | 1 | 2019 | 1457 | 0.100 |
Why?
|
| Humans | 22 | 2022 | 717237 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 34502 | 0.090 |
Why?
|
| Ventricular Function, Left | 4 | 2022 | 3433 | 0.090 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2015 | 1111 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2796 | 0.080 |
Why?
|
| Stroke Volume | 4 | 2022 | 4589 | 0.080 |
Why?
|
| Forecasting | 1 | 2016 | 2948 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2017 | 3433 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3837 | 0.070 |
Why?
|
| Patient Readmission | 1 | 2020 | 2987 | 0.070 |
Why?
|
| Heart Failure | 2 | 2020 | 10185 | 0.070 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 1196 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 18352 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2019 | 4373 | 0.060 |
Why?
|
| Animals | 8 | 2020 | 170890 | 0.060 |
Why?
|
| Phenotype | 1 | 2020 | 16404 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3703 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2022 | 62348 | 0.050 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 4531 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13307 | 0.050 |
Why?
|
| Fibrosis | 2 | 2017 | 1964 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10802 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 16017 | 0.040 |
Why?
|
| Male | 10 | 2022 | 351380 | 0.040 |
Why?
|
| Cardiac Output, Low | 1 | 2018 | 192 | 0.040 |
Why?
|
| Stroke | 1 | 2019 | 9512 | 0.040 |
Why?
|
| Female | 10 | 2022 | 377909 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2017 | 387 | 0.040 |
Why?
|
| Aging | 1 | 2015 | 8376 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2009 | 5948 | 0.040 |
Why?
|
| Propensity Score | 1 | 2022 | 1744 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 58528 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 470 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2935 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 3963 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2020 | 72614 | 0.020 |
Why?
|
| Aged | 5 | 2022 | 162856 | 0.020 |
Why?
|
| Collagen | 1 | 2017 | 2694 | 0.020 |
Why?
|
| Calcium | 1 | 2022 | 5832 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6778 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2020 | 39887 | 0.020 |
Why?
|
| Length of Stay | 1 | 2020 | 6280 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5141 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6753 | 0.020 |
Why?
|
| Middle Aged | 4 | 2020 | 215041 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15271 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 8095 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 13261 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12417 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 20095 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 4231 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39302 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 12433 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29226 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 23542 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 41095 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 212451 | 0.010 |
Why?
|
Concepts
(92)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_